Get the Stockscreener App
0.0571
3.63%
0.002
After Hours:
.06
0.0029
+5.08%
Hepion Pharmaceuticals Inc Stock (HEPA) Forecast
The Hepion Pharmaceuticals Inc (HEPA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $35.06, representing a +61,308% increase from the current price of $0.0571. The highest analyst price target is $51.57, and the lowest is $18.56.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HEPA Price Target
Average 26.12
(+45,652% Upside)
Is Hepion Pharmaceuticals Inc (HEPA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 0.00 | Neutral |
| STOCH(9,6) | 0.00 | Buy |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | 0.00 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.0177
Buy
|
0.00
Buy
|
| MA20 |
0.00886
Buy
|
0.00
Buy
|
| MA50 |
0.00354
Buy
|
0.00
Buy
|
| MA100 |
0.00177
Buy
|
0.00
Buy
|
| MA200 |
0.000886
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, HEPA could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on HEPA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 0 indicates that HEPA is oversold. This indicates that HEPA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 0 indicates that HEPA is oversold. This indicates that HEPA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that HEPA is oversold. This suggests that HEPA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 0 indicates that HEPA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HEPA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Hepion Pharmaceuticals Inc financial reports and earnings history, Hepion Pharmaceuticals Inc (HEPA) stock could reach $56.58 by 2030, $18.04 by 2040 and $64.65 by 2050. See the projected annual prices until 2050 of the Hepion Pharmaceuticals Inc stock below:
- Hepion Pharmaceuticals Inc (HEPA) is expected to reach an average price of $2.499 in 2035, with a high prediction of $3.7602 and a low estimate of $2.799. This indicates an $4,277% rise from the last recorded price of $0.0571.
- Hepion Pharmaceuticals Inc (HEPA) stock is projected to chart a bullish course in 2040, with an average price target of $18.03, representing an $31,480% surge from its current level. The forecast ranges from a conservative $18.13 to a sky-high $18.04.
- Our analysts predict Hepion Pharmaceuticals Inc (HEPA) to jump 62,655% by 2045, soaring from $35.78 to an average price of $35.83, potentially reaching $35.94. While $35.78 is the low estimate, the potential upside is significant.
- Hepion Pharmaceuticals Inc (HEPA) stock is expected to climb by 2050, reaching an average of $62.20, a $108.82K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $64.65 and $62.50, respectively, highlighting the market's uncertainty.
Hepion Pharmaceuticals Inc Stock (HEPA) Year by Year Forecast
Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2025
Hepion Pharmaceuticals Inc Stock (HEPA) is expected to reach an average price of $27.37 in 2025, with a high prediction of $54.05 and a low estimate of $0.69. This indicates an +47,836% rise from the last recorded price of $0.0571.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $19.56 | $18.56 | $51.57 | +34,154% |
| August, 2025 | $24.35 | $15.06 | $33.35 | +42,538% |
| September, 2025 | $22.73 | $10.94 | $24.13 | +39,714% |
| October, 2025 | $17.12 | $10.12 | $31.33 | +29,880% |
| November, 2025 | $9.2943 | $9.0911 | $18.92 | +16,177% |
| December, 2025 | $4.29 | $0.69 | $14.49 | +7,413% |
Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2026
The predicted value for Hepion Pharmaceuticals Inc (HEPA) in 2026 is set at an average of $12.58. Estimates vary from a peak of $24.47 to a trough of $0.6806, indicating an +21,927% surge from the present price of $0.0571.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.2775 | $0.6806 | $9.2775 | +10,894% |
| February, 2026 | $1.3351 | $2.1319 | $24.47 | +2,238% |
| March, 2026 | $0.9476 | $1.4845 | $11.46 | +1,560% |
| April, 2026 | $2.1633 | $0.7508 | $3.0492 | +3,689% |
| May, 2026 | $1.9759 | $4.8759 | $3.1476 | +3,360% |
| June, 2026 | $10.01 | $1.0599 | $11.18 | +17,433% |
| July, 2026 | $2.4041 | $2.4022 | $10.41 | +4,110% |
| August, 2026 | $4.8167 | $4.3073 | $3.8187 | +8,336% |
| September, 2026 | $0.6324 | $1.6261 | $4.3708 | +1,007% |
| October, 2026 | $2.2449 | $1.8418 | $1.3614 | +3,832% |
| November, 2026 | $0.8575 | $1.6512 | $1.0543 | +1,402% |
| December, 2026 | $6.0732 | $2.2606 | $3.758 | +10,536% |
Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Hepion Pharmaceuticals Inc (HEPA) is $6.3105, with a high forecast of $10.89 and a low forecast of $1.736. This indicates an +10,952% increase from the last price of $0.0571.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.2857 | $5.6826 | $4.2795 | +10,908% |
| February, 2027 | $9.6103 | $5.8889 | $7.3983 | +16,731% |
| March, 2027 | $6.714 | $7.5108 | $7.7046 | +11,658% |
| April, 2027 | $4.5265 | $4.9234 | $4.9171 | +7,827% |
| May, 2027 | $3.5391 | $1.736 | $1.3391 | +6,098% |
| June, 2027 | $10.90 | $4.9422 | $7.2148 | +18,987% |
| July, 2027 | $8.8253 | $9.1642 | $8.9579 | +15,356% |
| August, 2027 | $11.73 | $10.16 | $9.1819 | +20,443% |
| September, 2027 | $11.40 | $10.75 | $10.89 | +19,857% |
| October, 2027 | $8.6042 | $8.629 | $9.1207 | +14,969% |
| November, 2027 | $8.8227 | $8.6504 | $7.8176 | +15,351% |
| December, 2027 | $9.7724 | $10.36 | $9.6364 | +17,015% |
Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2028
In 2028, Hepion Pharmaceuticals Inc (HEPA) is projected to reach an average price of $5.5258, with a high projection of $10.92 and a low estimate of $0.1274. This indicates an +9,577% rise from the last price of $0.0571.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.25 | $8.9607 | $9.429 | +19,600% |
| February, 2028 | $10.46 | $10.86 | $10.26 | +18,214% |
| March, 2028 | $7.6372 | $10.75 | $10.92 | +13,275% |
| April, 2028 | $1.6938 | $2.3898 | $7.1705 | +2,866% |
| May, 2028 | $2.1645 | $0.3008 | $2.654 | +3,691% |
| June, 2028 | $1.022 | $0.1334 | $2.4883 | +1,690% |
| July, 2028 | $0.6634 | $0.1274 | $2.2694 | +1,062% |
| August, 2028 | $1.9463 | $0.1937 | $7.9137 | +3,309% |
| September, 2028 | $0.2788 | $1.6088 | $1.3825 | +388.31% |
| October, 2028 | $1.1814 | $0.492 | $1.118 | +1,969% |
| November, 2028 | $2.9771 | $1.9545 | $2.4558 | +5,114% |
| December, 2028 | $2.0296 | $2.2132 | $2.7392 | +3,455% |
Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2029
The 2029 price forecast for Hepion Pharmaceuticals Inc Stock (HEPA) is $30.81 on average, with a high prediction of $61.50 and a low estimate of $0.1158. This represents an +53,853% increase from the previous price of $0.0571.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.8153 | $3.4328 | $3.4763 | +6,582% |
| February, 2029 | $2.9579 | $3.0159 | $3.0316 | +5,080% |
| March, 2029 | $3.7004 | $3.271 | $3.4773 | +6,381% |
| April, 2029 | $2.073 | $2.883 | $3.2636 | +3,530% |
| May, 2029 | $2.9387 | $2.4834 | $2.3087 | +5,047% |
| June, 2029 | $2.7612 | $2.7912 | $2.6238 | +4,736% |
| July, 2029 | $0.3238 | $0.4938 | $0.8375 | +467.08% |
| August, 2029 | $0.0105 | $0.2895 | $0.6601 | -81.60% |
| September, 2029 | $0.3571 | $0.1158 | $0.3193 | +525.31% |
| October, 2029 | $68.30 | $0.1852 | $61.50 | +119.52K% |
| November, 2029 | $59.72 | $64.12 | $60.12 | +104.50K% |
| December, 2029 | $61.55 | $57.21 | $59.87 | +107.69K% |
Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2030
Hepion Pharmaceuticals Inc Stock (HEPA) is expected to reach an average price of $33.06 in 2030, with a high forecast of $64.16 and a low forecast of $1.9641. This signifies an +57,799% surge from the last price of $0.0571.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $45.78 | $43.37 | $56.58 | +80,076% |
| February, 2030 | $33.51 | $45.39 | $42.20 | +58,582% |
| March, 2030 | $8.8307 | $3.8181 | $61.19 | +15,365% |
| April, 2030 | $6.6002 | $2.4558 | $14.76 | +11,459% |
| May, 2030 | $2.6872 | $1.9641 | $36.13 | +4,606% |
| June, 2030 | $72.51 | $8.2935 | $49.51 | +126.89K% |
| July, 2030 | $66.74 | $65.93 | $63.24 | +116.79K% |
| August, 2030 | $62.17 | $63.37 | $64.16 | +108.78K% |
| September, 2030 | $57.79 | $58.39 | $60.78 | +101.12K% |
| October, 2030 | $35.53 | $43.23 | $45.21 | +62,116% |
| November, 2030 | $10.45 | $18.05 | $33.23 | +18,202% |
| December, 2030 | $12.48 | $13.66 | $9.7495 | +21,749% |
1.21%
1.51%
Cap:
|
Volume (24h):